FATE
Fate Therapeutics Inc.
$1.04
-$0.04(-3.70%)
27
Overall
--
Value
18
Tech
36
Quality
Market Cap
$128.02M
Volume
893.57K
52W Range
$0.66 - $4.20
Target Price
$4.95
EPS Estimates Overview
| Current Quarter | $-0.32 | Next Quarter | $-0.32 |
| Current Year | $-1.17 | Next Year | $-1.17 |
| QoQ Growth | +0.0% | YoY Growth | +0.0% |
| 3Y EPS CAGR | +7.5% | Target Price | $4.95 |
| Consensus | Buy | Upside | +376.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.04 | -3.7% | 893.57K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |